Geneleuk Biopharmaceutical

GeneLeuk Biopharmaceutical Co Ltd, a Sino-Us joint venture involving in R&D, manufacturing and marketing of Recombinant protein-based pharmaceuticals, passed the GMP certification of State Drug Administration of China in 1999, strictly observing the international standard of GLP, GCP and GMP.
Products include rhG-CSF, PEG-Filgrastim, rhInterferon, rhEPO,rhGH,FGF,TPA,rPA, TNF, IL-18,TPO etc.

Activity:

- Contract Manufacturing
- Manufacturing
- Market Research & Marketing
- Research & Development
- Sales & Distribution

Product / Technology type(s) covered:

- Bio
- Curative
- FP (finished products)
- Pharmaceuticals / Therapeutics
- Prescription drugs (Rx)
- Proteins

Therapeutic targets:

- Cancer
- Hematology
- Oncology
- Transplant

Markets Covered

a. HeadQuarter: China

b. Continent(s) active: Asia , North America , Central/South America

c. Countries active: South America

Corporate data:

Number of Employees: 100

Turnover:

Amount:	Year:	Currency:
5000000.0	2002	US Dollar

Year founded: 1999

Partners / Alliances: GeneLeuk Biopharmaceutical Co Ltd, a Sino-Us joint venture